MAS Insider Activity: 82,910-Share Sale and 82,910 Options Granted
Rhea-AI Filing Summary
Masco Corporation (MAS) insider transactions by Jai Shah on 08/22/2025. The filing shows multiple option-related activities and a bulk sale. Mr. Shah was issued three employee stock options that became exercisable in staggered years and vesting schedules: 44,700 options at a $35.52 exercise price (exercisable in installments beginning 02/07/2020), 22,490 options at $42.13 (beginning 02/09/2019), and 15,720 options at $33.75 (beginning 02/10/2018). On 08/22/2025 he sold 82,910 shares of Masco common stock for a weighted average price of $76.0382, leaving him with 39,638 shares beneficially owned. After the option grants and sale activity, total reported beneficial ownership is 122,548 shares. The sale prices reported ranged from $75.98 to $76.13.
Positive
- Full disclosure of option grants and sale prices including weighted average and price range
- Options retained total 82,910 with exercise prices well below the sale price, preserving potential upside
Negative
- Large sale of 82,910 shares reduced direct holdings to 39,638 shares, indicating a significant reduction in owned common stock
- Concentration risk from reliance on equity compensation remains given substantial option position relative to current direct holdings
Insights
TL;DR: Insider sold a meaningful block of shares while holding newly granted options, indicating portfolio rebalancing rather than increased ownership.
The Form 4 reports a sale of 82,910 Masco shares at a weighted average price of $76.0382, reducing direct holdings to 39,638 shares. Concurrently, Mr. Shah received three option grants totaling 82,910 options with exercise prices of $35.52, $42.13, and $33.75 and varying exercisable schedules. The option grants under the 2014 Long Term Stock Incentive Plan and the contemporaneous share sale offset each other in nominal share count terms. For investors, the transaction shows realized proceeds from previously held equity while maintaining long-term upside via stock options at substantially lower exercise prices than the sale price.
TL;DR: Disclosure is complete and follows Rule 16 reporting; multiple option grants and a sizeable sale are documented with required footnotes.
The filing includes clear footnote disclosure that the sale price is a weighted average from multiple transactions and confirms the grants were made under the Masco 2014 Long Term Stock Incentive Plan and exempt under Rule 16b-3. The reporting is signed by a power of attorney and provides exercisability schedules for each option. From a governance perspective, the form meets reporting standards and supplies the detailed exercise and ownership figures necessary for stakeholder review.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option | 44,700 | $0.00 | -- |
| Exercise | Employee Stock Option | 22,490 | $0.00 | -- |
| Exercise | Employee Stock Option | 15,720 | $0.00 | -- |
| Exercise | Common Stock | 44,700 | $35.52 | $1.59M |
| Exercise | Common Stock | 22,490 | $42.13 | $948K |
| Exercise | Common Stock | 15,720 | $33.75 | $531K |
| Sale | Common Stock | 82,910 | $76.0382 | $6.30M |
Footnotes (1)
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.98 to $76.13, inclusive. The reporting person undertakes to provide to Masco Corporation, any security holder of Masco Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. This option became exercisable in five equal annual installments commencing February 7, 2020. Grant of option under the Masco Corporation 2014 Long Term Stock Incentive Plan in transactions exempt under Rule 16b-3. This option became exercisable in five equal annual installments commencing February 9, 2019. This option became exercisable in five equal annual installments commencing February 10, 2018.
FAQ
What transactions did Jai Shah report on Masco (MAS) Form 4?
What are the exercise prices and exercisability schedules for the options granted?
Were the option grants issued under a named plan?